Yes, I read the article....I try to read most references/articles you and a few others post even if I don't understand all of the medical details. Gene editing is very interesting and obviously is the hot items in biotech's at the moment. While it shows promising potential, it seems to have a long ways to go and as your article mentions may have other risks/unintended consequences associated with it. I dabbled with some a couple investments in this field (CRSP & SGMO), but closed both positions recently to increase my CYDY position further.
Sorry for the delayed response. I have an unpaid membership here and they limit my number of daily messages.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.